History, Vision, Mission

MISSION
To integrate, educate, promote research and normalize cardiovascular interventionism in Latin America.

 

VISION
SOLACI will represent cardiovascular interventionism in Latin America: an active, transparent and dynamic organization of high impact on its members’ everyday life and high value for interventional cardiologists, the National societies and the industry.

 

HISTORY
In June 1993, a small group of Latin American interventional cardiologists gathered at the Cardiology Institute in Mexico, decided to create GLACI (Grupo Latinoamericano de Cardiólogos Intervencionistas) The Latin American Group of Interventional Cardiologists, a group of friends that reckoned the need to share experiences and knowledge, to contribute to the growth of our specialty in all Latin American countries.

 

In December 1994, the group held their first International Symposium at Calafate, in the South of Argentina; about one hundred interventional cardiologists from Latin America, USA, Europe and Asia, gathered in the vicinity of Perito Moreno glacier.

 

From that moment on, the group saw a fast growth, till in 1995 it turned into a Scientific Society, giving birth to SOLACI, the same year the first Congress was organized in Sao Paulo, Brazil.

 

SOLACI’s commitment to research and training resulted in increasingly important meetings and courses, the registry of interventions and procedures, research protocols, our web page, education and training grants, and continuous exchange between members.

 

The Society’s work has translated into a strong development of interventional cardiology in all countries of Latin America and the Caribbean.

 

Previous article
Next article

More articles by this author

Registration Open for Module 2 of the 2026 Annual Course: Multislice CT and Cardiovascular Magnetic Resonance Imaging

The Latin American Society of Interventional Cardiology (SOLACI) and the Argentine College of Interventional Cardioangiologists (CACI) announce the opening of registration for Module 2...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus release with two anticoagulant agents (rivaroxaban and...

Esta es una entrada en ingles

demo en ingles

test eng

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...